News about Drug Discovery & Development

Sun Pharma Signs Global Exclusive Deal with Philogen for Commercializing FIBROMUN

Under the terms of the agreement, Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun.

Drug Discovery & Development | 01/10/2024 | By Aishwarya |  513

Alembic Gets FDA Approval for Paliperidone Extended-Release Tablets

Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia and it is also indicated for treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants.

Drug Discovery & Development | 30/09/2024 | By Aishwarya |  513

AstraZeneca India Secures CDSCO Approval for Durvalumab

AstraZeneca Pharma India has been granted permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion from the Central Drugs Standard Control Organisation (CDSCO).

Drug Discovery & Development | 27/09/2024 | By Aishwarya |  578

Takara Bio Europe Rolls Out New NGS Profiling System and Chemistries

The Shasta Total RNA-Seq Kit is the first high-throughput single-cell total RNA profiling kit to offer full gene body coverage of up to 100,000 cells per run.

Drug Discovery & Development | 27/09/2024 | By Aishwarya |  419

Heron Therapeutics Gets FDA Approval for ZYNRELEF VAN

The VAN will replace the current vented vial spike and has the potential to simplify aseptic preparation, while also significantly reducing ZYNRELEF's withdrawal time down to between twenty and forty-five seconds.

Drug Discovery & Development | 26/09/2024 | By Aishwarya |  627

Lupin and Takeda to Commercialize Vonoprazan in India

Under the terms of this agreement, Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India.

Drug Discovery & Development | 19/09/2024 | By Aishwarya |  927

MinervaX Partners with Wacker Biotech for Prophylactic Vaccine

MinervaX has joined forces with Wacker Biotech to manufacture MinervaX's active protein ingredients of its GBS vaccine.

Drug Discovery & Development | 18/09/2024 | By Aishwarya |  510

Somite Therapeutics Receives FDA Orphan Drug and RPDD Designations for SMT-M01

Somite Therapeutics' SMT-M01 program leverages the company's proprietary AlphaStem AI platform to develop a novel cell replacement therapy for DMD.

Drug Discovery & Development | 17/09/2024 | By Aishwarya |  823

C2 PHARMA Rolls Outs Naphazoline Hydrochloride

Naphazoline HCL is effective in alleviating red eyes and nasal congestion, making it suitable for both prescription and over-the-counter products.

Drug Discovery & Development | 16/09/2024 | By Aishwarya |  705

GC Cell Signs Licensing Deal with PT Bifarma Adiluhung for Immuncell-LC

Bifarma is recognized for operating Indonesia's first GMP-certified cell therapy production facility and possesses a comprehensive sales and marketing infrastructure focused on oncology, specializing in a cold chain distribution network that spans across Indonesia.

Drug Discovery & Development | 11/09/2024 | By Aishwarya |  633